NCT01413607

Brief Summary

The objective of this study is to assess whether using a different type of suture (barbed sutures) during partial nephrectomy results in fewer postoperative complications than with traditional sutures (non-barbed). The most common complications are urine leakage and bleeding. The investigators believe the barbed suture is less technically difficult to use and will allow the surgeon to better repair the hole left in the kidney after the tumor is removed.

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
65

participants targeted

Target at P25-P50 for phase_4

Geographic Reach
1 country

1 active site

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 2, 2011

Completed
8 days until next milestone

First Posted

Study publicly available on registry

August 10, 2011

Completed
22 days until next milestone

Study Start

First participant enrolled

September 1, 2011

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 1, 2012

Completed
Last Updated

August 2, 2021

Status Verified

July 1, 2021

Enrollment Period

5 months

First QC Date

August 2, 2011

Last Update Submit

July 27, 2021

Conditions

Keywords

nephrectomyself retaining sutureslaparoscopy

Outcome Measures

Primary Outcomes (2)

  • Postoperative bleeding

    Patients will be considered positive for bleeding if they have any of gross hematuria, need for transfusion in the postoperative period not believed to be from intraoperative bleeding or need for angioembolization.

    Data will be collected up to 12 weeks following the procedure

  • Urinary leakage

    Urinary leakage is defined as any leakage requiring instrumentation (stent insertion, retrograde pyelogram or percutaneous drainage) or prolonged stay of drain due to high output (\>4 days).

    Data will be collected up to 12 weeks following the procedure

Secondary Outcomes (4)

  • Warm or cold ischemia time.

    Intraoperative

  • Total operative time

    Intraoperative

  • Length of hospital stay measured in days

    Postoperative. Average stay following partial nephrectomy is 3 days

  • Estimated blood loss during the procedure

    Intraoperative

Study Arms (2)

Quill knotless tissue-closure device

EXPERIMENTAL

During partial nephrectomy participants in this group will receive the Quill Knotless Tissue-Closure device (Angiotech Pharmaceuticals) to close the central defect in their kidney.

Device: Quill knotless tissue-closure device

2-0 absorbable vicryl suture

ACTIVE COMPARATOR

Participants in this group will be receiving traditional 2-0 vicryl sutures (Ethicon) during partial nephrectomy.

Device: 2-0 absorbable vicryl suture

Interventions

The Quill knotless tissue-closure device is a barbed suture that allows the surgeon to keep tissue approximation without maintaining tension on the suture.

Also known as: Quill Knotless Tissue-Closure Device (RA-1000Q)
Quill knotless tissue-closure device

In the control group a traditional 2-0 absorbable vicryl suture (Ethicon) will be used to close the central defect in the kidney.

Also known as: Ethicon 2-0 absorbable vicryl suture
2-0 absorbable vicryl suture

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • any person who is being treated for kidney cancer with partial nephrectomy.

You may not qualify if:

  • those from whom we cannot obtain adequate informed consent.
  • those that are converted from partial to radical nephrectomy intraoperatively.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

CDHA QEII site

Halifax, Nova Scotia, B3H 3A7, Canada

Location

Related Publications (6)

  • Becker F, Siemer S, Kamradt J, Zwergel U, Stockle M. Important aspects of organ-preserving surgery for renal tumors: indications, new standards, and oncological outcomes. Dtsch Arztebl Int. 2009 Feb;106(8):117-22. doi: 10.3238/arztebl.2009.0117. Epub 2009 Feb 20.

    PMID: 19568369BACKGROUND
  • Becker F, Van Poppel H, Hakenberg OW, Stief C, Gill I, Guazzoni G, Montorsi F, Russo P, Stockle M. Assessing the impact of ischaemia time during partial nephrectomy. Eur Urol. 2009 Oct;56(4):625-34. doi: 10.1016/j.eururo.2009.07.016. Epub 2009 Jul 28.

    PMID: 19656615BACKGROUND
  • Gill IS, Kavoussi LR, Lane BR, Blute ML, Babineau D, Colombo JR Jr, Frank I, Permpongkosol S, Weight CJ, Kaouk JH, Kattan MW, Novick AC. Comparison of 1,800 laparoscopic and open partial nephrectomies for single renal tumors. J Urol. 2007 Jul;178(1):41-6. doi: 10.1016/j.juro.2007.03.038. Epub 2007 May 11.

    PMID: 17574056BACKGROUND
  • Nguyen MM, Gill IS. Halving ischemia time during laparoscopic partial nephrectomy. J Urol. 2008 Feb;179(2):627-32; discussion 632. doi: 10.1016/j.juro.2007.09.086. Epub 2007 Dec 21.

    PMID: 18082215BACKGROUND
  • Turna B, Frota R, Kamoi K, Lin YC, Aron M, Desai MM, Kaouk JH, Gill IS. Risk factor analysis of postoperative complications in laparoscopic partial nephrectomy. J Urol. 2008 Apr;179(4):1289-94; discussion 1294-5. doi: 10.1016/j.juro.2007.11.070. Epub 2008 Mar 4.

    PMID: 18289584BACKGROUND
  • El-Ghazaly, T.H. and Rendon, R.A. 2011. Perioperative outcomes of laparoscopic partial nephrectomy using self-retaining sutures (SRS) and early clamp removal versus conventional kidney and collecting system repair. Canadian Urological Association Journal 5(3 suppl 1) s3-s114 sub-article 66

    BACKGROUND

MeSH Terms

Conditions

Kidney Neoplasms

Condition Hierarchy (Ancestors)

Urologic NeoplasmsUrogenital NeoplasmsNeoplasms by SiteNeoplasmsFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesKidney DiseasesUrologic DiseasesMale Urogenital Diseases

Study Officials

  • Ricardo A Rendon, MD

    Capital distrcit health authority, Canada

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
phase 4
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
urologist

Study Record Dates

First Submitted

August 2, 2011

First Posted

August 10, 2011

Study Start

September 1, 2011

Primary Completion

February 1, 2012

Last Updated

August 2, 2021

Record last verified: 2021-07

Locations